At the heart of the project is the idea of developing an IOL that can safely prevent the occurrence of negative dysphotopsia (ND).
ND is a post-surgery complication that occurs in up to 15% of patients following implantation of modern foldable lenses, e.g. in the treatment of cataracts. Patients with this complication complain of an irritating, blinder-like restriction of the visual field which is most likely caused by shadows. These shadows are attributed to edge glare phenomena.